Comparison Chart Metagenomi Therapeutics, Inc.
Equities
MGX
US59102M1045
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.740 USD | -1.14% |
|
+8.75% | +7.41% |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| METAGENOMI THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -1.14% | +8.75% | +7.41% | -13.86% | - | 66.21M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- MGX Stock
- Charts Metagenomi Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
